Leukaemia and lymphoma patients to benefit as drug is added to PBS

By Lyne Mp David Gillespie
October 11 2017 - 4:00pm
Lyne MP David Gillespie: The $466 million listing on the pharmaceutical benefits scheme will save eligible leukaemia and lymphoma patients.patients many thousands of dollars.
Lyne MP David Gillespie: The $466 million listing on the pharmaceutical benefits scheme will save eligible leukaemia and lymphoma patients.patients many thousands of dollars.

Hundreds of families will soon benefit from access to affordable new medicine for leukaemia and lymphoma patients.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options